國立虎尾科技大學 |

Antibodies for Treating Cancer = Basics, Development, and Applications /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Antibodies for Treating Cancer/ by Melvyn Little.
其他題名:	Basics, Development, and Applications /
作者:	Little, Melvyn.
面頁冊數:	XI, 151 p. 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cancer Research. -
電子資源:	https://doi.org/10.1007/978-3-030-72599-0
ISBN:	9783030725990

Antibodies for Treating Cancer = Basics, Development, and Applications /
Little, Melvyn.

Antibodies for Treating CancerBasics, Development, and Applications /[electronic resource] :by Melvyn Little. - 1st ed. 2021. - XI, 151 p. 34 illus. in color.online resource.

1 Life-saving antibodies – history of immunization -- 2 Current approaches for immunising against cancer -- 3 Function and Structure of antibodies -- 4 Of mice and men - production of therapeutic antibodies -- 5 Novel modular antibodies -- 6 Antibodies as “Magic Bullets” -- 7 Mediation of tumor cell destruction -- 8 Engagement of immune killer cells -- 9 Approved antibodies for cancer therapy -- 10 Bringing therapeutic antibodies on the market -- 11 Future developments – outlook.

This book presents a compact overview of the history, evolution and fascinating novel applications of antibodies for the treatment of cancer, leading the reader step by step to the latest advances. Interesting anecdotes, together with self-explanatory and clearly structured figures with a humorous touch, facilitate the reader’s understanding of this complex topic. Clinical cases round out the book, making it a valuable aid for professionals in their everyday practice. The growing importance of the topics covered here was highlighted by the joint award of the 2018 Nobel Prize in Chemistry to Frances H. Arnold (directed evolution of enzymes), George P. Smith (phage display of peptides) and Sir Gregory P. Winter (phage display of antibodies). Furthermore, the 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. Many of the antibodies that are now being brought to market target precisely these immune checkpoint modulators. The book addresses a broad readership, ranging from professionals and experts in the field to residents and medical students.

ISBN: 9783030725990

Standard No.: 10.1007/978-3-030-72599-0doiSubjects--Topical Terms:

668358
Cancer Research.

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Antibodies for Treating Cancer = Basics, Development, and Applications /
LDR:03007nam a22003975i 4500 001 1053998
003 DE-He213
005 20210921170013.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030725990 $9 978-3-030-72599-0
024 7 $a 10.1007/978-3-030-72599-0 $2 doi
035 $a 978-3-030-72599-0
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
100 1 $a Little, Melvyn. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1263333
245 1 0 $a Antibodies for Treating Cancer $h [electronic resource] : $b Basics, Development, and Applications / $c by Melvyn Little.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XI, 151 p. 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1 Life-saving antibodies – history of immunization -- 2 Current approaches for immunising against cancer -- 3 Function and Structure of antibodies -- 4 Of mice and men - production of therapeutic antibodies -- 5 Novel modular antibodies -- 6 Antibodies as “Magic Bullets” -- 7 Mediation of tumor cell destruction -- 8 Engagement of immune killer cells -- 9 Approved antibodies for cancer therapy -- 10 Bringing therapeutic antibodies on the market -- 11 Future developments – outlook.
520 $a This book presents a compact overview of the history, evolution and fascinating novel applications of antibodies for the treatment of cancer, leading the reader step by step to the latest advances. Interesting anecdotes, together with self-explanatory and clearly structured figures with a humorous touch, facilitate the reader’s understanding of this complex topic. Clinical cases round out the book, making it a valuable aid for professionals in their everyday practice. The growing importance of the topics covered here was highlighted by the joint award of the 2018 Nobel Prize in Chemistry to Frances H. Arnold (directed evolution of enzymes), George P. Smith (phage display of peptides) and Sir Gregory P. Winter (phage display of antibodies). Furthermore, the 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. Many of the antibodies that are now being brought to market target precisely these immune checkpoint modulators. The book addresses a broad readership, ranging from professionals and experts in the field to residents and medical students.
650 2 4 $a Cancer Research. $3 668358
650 1 4 $a Oncology. $3 593951
650 0 $a Cancer research. $3 1253664
650 0 $a Oncology . $3 1253469
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030725983
776 0 8 $i Printed edition: $z 9783030726003
776 0 8 $i Printed edition: $z 9783030726010
856 4 0 $u https://doi.org/10.1007/978-3-030-72599-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)